Listen

Description

Summary


In this conversation, Gregory Austin and Chad Briscoe interview Chuck Piccirillo, CEO of Zealic Health, about his experience in the healthcare industry and the focus on patient-centric solutions. Chuck shares his personal journey with colitis and how it ultimately inspired him to start Zealic Health. The company aims to provide highly patient-centric digital platforms to improve care and treatment in the healthcare industry. Chuck also shares the story of how Zealic Health adapted to the war in Ukraine and relocated their employees to Poland.

The panel tackles the tough questions around the new LDT as a Medical Device final ruling by the FDA. They then discuss how AI is helping doctors detect cancer and in making better diagnostic decisions.

Takeaways


Sound Bites


Chapters

01:33 Introduction and Background

04:03 The Crohn’s & Colitis Foundation and Chuck’s struggle with Colitis

07:49 Patient-Centric Solutions in Healthcare and Zealic Health

13:26 Plan B - Moving offices from Ukraine to Poland

20:02 New News!! - The Controversy of LDTs Becoming Medical Devices

27:20 Implications of healthcare and regulations as it applies to AI

30:07 How AI Aids in Diagnosis



New News Story: House committee tells FDA to suspend lab developed test rule

https://www.healthcaredive.com/news/house-committee-fda-suspend-ldt-rule/721362/ 



How to reach us:

Crohn's & Colitis Foundation

https://www.crohnscolitisfoundation.org/ 

Chuck Piccirillo

https://www.linkedin.com/in/cpiccirillo/ 

Zealic Health - http://www.zealichealth.com

Dr. Chad Briscoe

https://www.linkedin.com/in/chadbriscoe/ 

Celerion - https://www.celerion.com/  

Gregory Austin

https://www.linkedin.com/in/gregoryaustin1/ 

...